Release date: 14 February 2005
Promoter – Financial Intermediary
A private law foundation created by public authorities in 2001 for the purpose of developing a national centre for hadrontherapy. The founders include two large research and health care institutes , two oncological hospitals, the Italian National Neurological Institute and a private scientific foundation.Contact point: Dott. Sandro Rossi
Phone : 02.6448.5410
Location
Description
Construction near Pavia (N. Italy) of a new cancer treatment structure offering highly specialist services based on radiation therapy, proton therapy and carbon ion therapy, an advanced clinical research centre and ancillary facilities.
Objectives
Treatment of specific types of cancer located in soft/deep tissues through sophisticated innovative nuclear applications known as "hadrontherapy".
Sector(s)
Proposed EIB finance (Approximate amount)
Approximately EUR 60 million
Total cost (Approximate amount)
Approximately EUR 130 million
Environmental aspects
EU Directive 97/11/EC does not specifically mention hospital activities on Environmental Impact Assessment (EIA). As the project includes elements of construction in urban settings it might be construed as an Annex II development. The basis for whether an EIA has been requested by the competent authorities or not, local planning and approval process and actual/possible significant impacts on protected flora and fauna (Habitats and Birds Directives) will be verified during project appraisal.
Procurement
Promoter's procurement procedures will be verified during appraisal.
Status
Signed - 17/06/2008
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).